SENS-AI
DCP Trading Update Bullish

DIS-CHEM PHARMACIES LIMITED - Trading Update For The Period 1 September 2025 To 16 February 2026

Dis-Chem Pharmacies Limited
Full analysis

What this filing means

Dis-Chem delivered a strong 10.1% revenue increase driven by its new 'Better Rewards' program and wholesale expansion, though the heavy investment in customer discounts may pressure short-term margins.

Dis-Chem is selling more medicine and healthcare products than before, growing its sales by over 10%. Their new loyalty program has been a big hit with shoppers, but because they are giving so many discounts to win customers, there is a risk that their profit margins might get squeezed even though they are gaining market share.

Bull case

  • Strong Group revenue growth of 10.1% for the 24-week period, indicating robust operational momentum.
  • The 'Better Rewards' loyalty program is driving significant market share gains, with volume growth of 8.0% massively outperforming the market average of 1.3%.
  • Wholesale segment delivered exceptional performance with a 15.7% revenue increase, supported by the expansion of the TLC franchise network to 281 stores.
  • Strategic partnerships, notably with Capitec, and high demand for GLP-1 pharmacy products are driving shared value and basket frequency.
  • Retail revenue under the new loyalty program grew 10.4%, attracting 550,000 new shoppers since October 2025.

Bear case

  • Aggressive discounting through the 'Better Rewards' program has returned R410 million to customers, suggesting potential gross margin compression.
  • Volume growth (20.9%) is outpacing revenue growth (19.4%) in participating brands, signaling a lower price-per-unit and negative pricing power.
  • Pharmacy growth is heavily reliant on high-demand GLP-1 drugs, introducing concentration risk should demand or pricing for this category shift.
  • The stock trades at a premium P/E of 25.4x, leaving little room for error if the margin investment does not yield sufficient operating leverage.
View original SENS announcement

AI-generated summary by SENS-AI, based on the original JSE SENS filing.

SENS-AI conclusion

Dis-Chem has demonstrated impressive top-line resilience with 10.1% Group revenue growth and significant market share gains (+0.8 percentage points) following the launch of its 'Better Rewards' programme. While the bull case is supported by strong volume growth of 8.0% versus a market average of 1.3%, the bear concern regarding the R410 million 'returned to customers' suggests a deliberate strategy of sacrificing gross margin for long-term customer acquisition. With the stock trading near 52-week highs and a P/E of 25.4x, the market has already priced in much of this operational success. Investor Takeaway: This is a high-quality growth story where the focus has shifted from store rollouts to loyalty-driven wallet share, making it a 'hold' for those concerned about margin compression but a 'buy' for those betting on long-term market dominance.

Operational momentum is strong but priced in at 25x earnings. Maintain current positions; look for confirmation of margin stability in the next full results before adding.

Evidence from the filing

  • Dis-Chem achieved strong top-line growth, with Group revenue increasing by a robust 10.1% for the 24-week period

    “Group revenue increased by 10.1%”

  • The newly launched 'Better Rewards' loyalty program is a significant success, driving a 10.4% increase in retail revenue

    “Retail revenue for the 17 weeks under the Better Rewards programme increased by 10.4% compared to the corresponding period, with volume growth of 5.2%.”

  • The Group has significantly outperformed the market, achieving volume growth of 8.0% in its core retail categories

    “Dis-Chem achieved volume growth of 8.0% against a market volume growth of 1.3%, increasing its market share across all core categories by 0.8 percentage points.”

  • Strategic partnerships, such as with Capitec, are driving shared value

    “strategic partnerships like Capitec, where the Capitec boost is driving shared value for both brands and our shared customers.”

  • The wholesale segment is demonstrating robust growth, with revenue increasing by 15.7%

    “Wholesale revenue increased by 15.7% during the period compared to the corresponding period.”

  • Significant Margin Erosion from Loyalty Programme

    “In the 17 weeks since launch, we have returned R410 million in savings directly to customers; funds that our customers can reinvest directly into their health, making healthcare more accessible, more affordable and more meaningful.”

  • Market Share Gains at the Expense of Pricing Power

    “Revenue growth of participating Better Rewards brands increased by 19.4% with volume growth of 20.9%. The consistency of an always-on, health-relevant, lowest price basket is driving increased shopping frequency.”

  • Concentration Risk in Pharmacy Revenue Growth

    “Under the Better Rewards programme, pharmacy revenue grew by 13.7% driven by increasing pharmacy boost engagement and high demand for GLP-1 drugs.”

  • Unaudited Figures Underpin a Stretched Valuation

    “The financial information contained in this trading update has not been reviewed or reported on by the Group's independent auditors, Forvis Mazars.”
Category
Trading Update
Published
Feb 20, 2026

More on Dis-Chem Pharmacies Limited

Dis-Chem Pharmacies Limited (DCP) share price All Dis-Chem Pharmacies Limited SENS announcements

Related filings